Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Barclay

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Rheumatology (Oxford, England)|November 29, 2023
Colchicine: the good, the bad, the ugly and how to minimize the risksLisa K Stamp, Carl Horsley, Leanne Te Karu, et al.
BMJ Open|March 21, 2018
'It feels like being trapped in an abusive relationship': bullying prevalence and consequences in the New Zealand senior medical workforce: a cross-sectional studyCharlotte N L Chambers, Christopher M A Frampton, Martin McKee, et al.
The New Zealand Medical Journal|March 19, 2005
Measurement of thiopurine methyl transferase activity guides dose-initiation and prevents toxicity from azathioprineChristiaan Sies, Christopher Florkowski, Peter George, et al.
Journal of Clinical Gastroenterology|June 29, 2012
Perianal disease combined with NOD2 genotype predicts need for IBD-related surgery in Crohn's disease patients from a population-based cohortBushra Farah Nasir, Lyn Griffiths, Aslam Nasir, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 13, 2018
A Pilot Randomized Controlled Double-Blind Trial of High- Versus Low-Dose Weekly Folic Acid in People With Rheumatoid Arthritis Receiving MethotrexateLisa K Stamp, John L OʼDonnell, Christopher Frampton, et al.
Arthritis Research & Therapy|December 23, 2017
The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Rheumatology (Oxford, England)|August 15, 2018
Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Annals of the Rheumatic Diseases|August 24, 2017
Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension studyLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 3, 2013
An envirogenomic signature is associated with risk of IBD-related surgery in a population-based Crohn's disease cohortBushra F Nasir, Lyn R Griffiths, Aslam Nasir, et al.
The New Zealand Medical Journal|July 2, 2010
New Zealand Society of Gastroenterology statement on the use of biological therapy in inflammatory bowel diseaseMichael Schultz, Richard Gearry, Russell Walmsley, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|November 29, 2023
Colchicine: the good, the bad, the ugly and how to minimize the risksLisa K Stamp, Carl Horsley, Leanne Te Karu, et al.
BMJ Open|March 21, 2018
'It feels like being trapped in an abusive relationship': bullying prevalence and consequences in the New Zealand senior medical workforce: a cross-sectional studyCharlotte N L Chambers, Christopher M A Frampton, Martin McKee, et al.
The New Zealand Medical Journal|March 19, 2005
Measurement of thiopurine methyl transferase activity guides dose-initiation and prevents toxicity from azathioprineChristiaan Sies, Christopher Florkowski, Peter George, et al.
Journal of Clinical Gastroenterology|June 29, 2012
Perianal disease combined with NOD2 genotype predicts need for IBD-related surgery in Crohn's disease patients from a population-based cohortBushra Farah Nasir, Lyn Griffiths, Aslam Nasir, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 13, 2018
A Pilot Randomized Controlled Double-Blind Trial of High- Versus Low-Dose Weekly Folic Acid in People With Rheumatoid Arthritis Receiving MethotrexateLisa K Stamp, John L OʼDonnell, Christopher Frampton, et al.
Arthritis Research & Therapy|December 23, 2017
The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Rheumatology (Oxford, England)|August 15, 2018
Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Annals of the Rheumatic Diseases|August 24, 2017
Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension studyLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 3, 2013
An envirogenomic signature is associated with risk of IBD-related surgery in a population-based Crohn's disease cohortBushra F Nasir, Lyn R Griffiths, Aslam Nasir, et al.
The New Zealand Medical Journal|July 2, 2010
New Zealand Society of Gastroenterology statement on the use of biological therapy in inflammatory bowel diseaseMichael Schultz, Richard Gearry, Russell Walmsley, et al.
Pageof 4